Alemtuzumab y síndrome poliglandular autoinmune con diabetes mellitus tipo 1
DOI:
10.1016/j.nrl.2023.07.001
Publication Date:
2024-02-03T20:08:13Z
AUTHORS (3)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (10)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....